|Bid||237.60 x 800|
|Ask||237.64 x 800|
|Day's Range||236.21 - 243.01|
|52 Week Range||199.11 - 255.21|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||29.23|
|Earnings Date||Feb 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||204.14|
Benefits of robust adoption of Xeon processors are likely to get reflected in Intel's (INTC) Q4 results. However, sluggishness in the PC business is expected to have affected performance.
Taiwan Semiconductor's (TSM) fourth-quarter results are likely to have benefited from robust technology portfolio and new product introductions.
Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling more scientists to realize the advantages of repeatability and performance for both routine and complex laboratory workflows.
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China. If you were a passive index fund investor, you had seen gains of 31% in your equity portfolio in 2019. However, if you were an […]
Waters Corporation (NYSE:WAT) will webcast its Q4 2019 financial results conference call live on Tuesday, February 4th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose "Investors" and click on the Live Webcast. A replay of the webcast will be available until February 11th at midnight eastern time.
Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan recognizes Waters Corporation with the 2019 Global New Product Innovation Award for its smart BioAccord Liquid Chromatography-Mass Spectrometry (LC-MS) System. It is the first smart MS-enabled biopharmaceutical solution with intelligent software and chemistries, which deliver high levels of reliability, sensitivity, and detection.
Waters Corporation (NYSE:WAT) Christopher J. O’Connell, Chairman and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 13th, 2020 at 7:30 a.m. Pacific Time.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Waters Corporation...